Senior Manager-Associate Director, Strategy and Competitive Intelligence

About the Role

Harbour BioMed is seeking a Senior Manager/Associate Director of Strategy and Competitive Intelligence to shape and sharpen the strategic direction of our growing pipeline. Sitting at the intersection of science, strategy, and business development, you will translate complex global intelligence into clear, actionable insights that inform leadership decisions on portfolio prioritization, asset positioning, and deal-making across our core therapeutic areas (immuno-oncology, autoimmune diseases) and key modalities (bispecific antibodies, ADCs, and our proprietary HCAb platform).

Key Responsibilities

• Portfolio Strategy & Prioritization. Develop and maintain Harbour's portfolio strategy. Partner with TA leaders, clinicians, and technology heads to identify high-potential opportunities. Lead asset prioritization (including methodology design) and build governance mechanisms for managing the portfolio in a dynamic competitive landscape.

• Competitive Intelligence & Landscaping. Lead systematic competitive intelligence (CI) activities revolving around our core TA and modality focus. Build, maintain, and refresh competitive landscapes for top-priority projects. Continuously track strategic deals (licensing, M&A, partnerships) across the global biopharma industry, with rigorous source triangulation and clear insight generation.

• Intelligence Sourcing. Synthesize intelligence from a broad range of sources: commercial databases (Cortellis/ Evaluate/ Biomedtracker), major medical and BD conferences (ASCO/ AACR/ JPM ), industry trade publications (Endpoints/ BioCentury/ STAT), and press release platforms etc. Translate findings into executive-ready briefings, landscape reports, and strategic recommendations.

• Governance & Decision Support. Implement governance frameworks and decision-support mechanisms across Strategy, R&D, BD, and Commercial functions to ensure portfolio and strategic decisions are evidence-based, timely, and aligned to Harbour's long-term vision.

• Executive Communication. Deliver CEO-grade outputs, concise memos, executive presentations, and deep-dive strategic reports tailored to senior leadership and cross-functional stakeholders.

Required Qualifications

• 8+ years of relevant experience in TA Strategy, Portfolio Management, Business Development, New Product Planning, Competitive Intelligence, or top-tier management consulting (life sciences focus).

• Solid understanding of the end-to-end drug discovery and development cycle, with familiarity spanning early discovery through mid- to late-stage clinical development.

• Strong project management skills and demonstrated experience working with senior management in matrix organizations, with strong cross-functional collaboration across discovery, clinical, regulatory affairs, and BD teams.

• Hands-on proficiency with mainstream intelligence and clinical trial databases.

• Excellent written and verbal communication in both English and Chinese; CEO-memo-style writing experience is highly valued.

• Advanced degree (Ph.D., M.D., M.S., or equivalent) in life sciences, medicine, pharmacology, or a related field.

Preferred Qualifications

• Prior experience in Harbour's core therapeutic areas: immuno-oncology, autoimmune and inflammatory diseases.

• Direct experience with our key modalities: bispecific antibodies (BsAb), antibody-drug conjugates (ADC), and T-cell engagers (TCE).

• Familiarity with various industry intelligence sources and global regulatory agency & laws.

• Prior experience supporting executive-level BD evaluations, strategic landscape reports, or portfolio governance processes at MNC or top Biotech/biopharma.